Pertuzumab
Pertuzumab – HER2 Dimerization Inhibitor Monoclonal Antibody
Pertuzumab is a recombinant humanized monoclonal antibody designed to specifically target the human epidermal growth factor receptor 2 (HER2). It plays a crucial role in the treatment of HER2-positive breast cancers by inhibiting receptor dimerization and downstream signaling pathways responsible for tumor growth.
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.